{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:55:09Z","timestamp":1794887709889,"version":"4.9.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T00:00:00Z","timestamp":1561680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T00:00:00Z","timestamp":1561680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670746"],"award-info":[{"award-number":["81670746"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800424"],"award-info":[{"award-number":["81800424"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370391"],"award-info":[{"award-number":["81370391"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670230"],"award-info":[{"award-number":["81670230"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["HL134849"],"award-info":[{"award-number":["HL134849"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["HL134849"],"award-info":[{"award-number":["HL134849"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>NLR Family CARD Domain Containing 5 (NLRC5), an important immune regulator in innate immunity, is involved in regulating inflammation and antigen presentation. However, the role of NLRC5 in vascular remodeling remains unknown. Here we report the role of NLRC5 on vascular remodeling and provide a better understanding of its underlying mechanism. <jats:italic>Nlrc5<\/jats:italic> knockout (<jats:italic>Nlrc5<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup>) mice exhibit more severe intimal hyperplasia compared with wild-type mice after carotid ligation. Ex vivo data shows that NLRC5 deficiency leads to increased proliferation and migration of human aortic smooth muscle cells (HASMCs). NLRC5 binds to PPAR\u03b3 and inhibits HASMC dedifferentiation. NACHT domain of NLRC5 is essential for the interaction with PPAR\u03b3 and stimulation of PPAR\u03b3 activity. Pioglitazone significantly rescues excessive intimal hyperplasia in <jats:italic>Nlrc5<\/jats:italic><jats:sup><jats:italic>\u2212\/\u2212<\/jats:italic><\/jats:sup> mice and attenuates the increased proliferation and dedifferentiation in <jats:italic>NLRC5-deficient<\/jats:italic> HASMCs. Our study demonstrates that NLRC5 regulates vascular remodeling by directly inhibiting SMC dysfunction via its interaction with PPAR\u03b3.<\/jats:p>","DOI":"10.1038\/s41467-019-10784-y","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T10:03:14Z","timestamp":1561716194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["NLRC5 inhibits neointima formation following vascular injury and directly interacts with PPAR\u03b3"],"prefix":"10.1038","volume":"10","author":[{"given":"Peipei","family":"Luan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixia","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Handan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0679-8477","authenticated-orcid":false,"given":"Dali","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9523-3859","authenticated-orcid":false,"given":"Mark W.","family":"Feinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhui","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2937-0024","authenticated-orcid":false,"given":"Wenhui","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,28]]},"reference":[{"key":"10784_CR1","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/nm1102-1249","volume":"8","author":"VJ Dzau","year":"2002","unstructured":"Dzau, V. J., Braun-Dullaeus, R. C. & Sedding, D. G. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat. Med. 8, 1249\u20131256 (2002).","journal-title":"Nat. Med."},{"key":"10784_CR2","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1161\/ATVBAHA.107.161224","volume":"28","author":"A Schober","year":"2008","unstructured":"Schober, A. Chemokines in vascular dysfunction and remodeling. Arterioscler. Thromb. Vasc. Biol. 28, 1950\u20131959 (2008).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10784_CR3","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1161\/CIRCRESAHA.116.301312","volume":"116","author":"G Tellides","year":"2015","unstructured":"Tellides, G. & Pober, J. S. Inflammatory and immune responses in the arterial media. Circ. Res. 116, 312\u2013322 (2015).","journal-title":"Circ. Res."},{"key":"10784_CR4","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1161\/CIRCULATIONAHA.114.011090","volume":"130","author":"AP Sage","year":"2014","unstructured":"Sage, A. P. et al. MHC Class II-restricted antigen presentation by plasmacytoid dendritic cells drives proatherogenic T cell immunity. Circulation 130, 1363\u20131373 (2014).","journal-title":"Circulation"},{"key":"10784_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6160","volume":"5","author":"SM Zhang","year":"2014","unstructured":"Zhang, S. M. et al. Interferon regulatory factor 9 is critical for neointima formation following vascular injury. Nat. Commun. 5, 5160 (2014).","journal-title":"Nat. Commun."},{"key":"10784_CR6","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1073\/pnas.1018515108","volume":"108","author":"JE Cole","year":"2011","unstructured":"Cole, J. E. et al. Unexpected protective role for Toll-like receptor 3 in the arterial wall. Proc. Natl Acad. Sci. USA 108, 2372\u20132377 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10784_CR7","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.bbrc.2011.07.006","volume":"411","author":"S Schlaweck","year":"2011","unstructured":"Schlaweck, S. et al. Critical role of nucleotide-binding oligomerization domain-like receptor 3 in vascular repair. Biochem. Biophys. Res. Commun. 411, 627\u2013631 (2011).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10784_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","volume":"20","author":"CA Janeway Jr.","year":"2002","unstructured":"Janeway, C. A. Jr. & Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol. 20, 197\u2013216 (2002).","journal-title":"Annu. Rev. Immunol."},{"key":"10784_CR9","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.1371\/journal.ppat.0030152","volume":"3","author":"JC Sirard","year":"2007","unstructured":"Sirard, J. C., Vignal, C., Dessein, R. & Chamaillard, M. Nod-like receptors: cytosolic watchdogs for immunity against pathogens. PLoS Pathog. 3, e152 (2007).","journal-title":"PLoS Pathog."},{"key":"10784_CR10","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.immuni.2007.10.002","volume":"27","author":"TD Kanneganti","year":"2007","unstructured":"Kanneganti, T. D., Lamkanfi, M. & Nunez, G. Intracellular NOD-like receptors in host defense and disease. Immunity 27, 549\u2013559 (2007).","journal-title":"Immunity"},{"key":"10784_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/ni.1985","volume":"12","author":"TA Kufer","year":"2011","unstructured":"Kufer, T. A. & Sansonetti, P. J. NLR functions beyond pathogen recognition. Nat. Immunol. 12, 121\u2013128 (2011).","journal-title":"Nat. Immunol."},{"key":"10784_CR12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3389\/fimmu.2013.00333","volume":"4","author":"Y Zhong","year":"2013","unstructured":"Zhong, Y., Kinio, A. & Saleh, M. Functions of NOD-Like Receptors in Human Diseases. Front. Immunol. 4, 333 (2013).","journal-title":"Front. Immunol."},{"key":"10784_CR13","doi-asserted-by":"publisher","first-page":"e98899","DOI":"10.1371\/journal.pone.0098899","volume":"9","author":"N Castano-Rodriguez","year":"2014","unstructured":"Castano-Rodriguez, N., Kaakoush, N. O., Goh, K. L., Fock, K. M. & Mitchell, H. M. The NOD-like receptor signalling pathway in Helicobacter pylori infection and related gastric cancer: a case-control study and gene expression analyses. PloS ONE 9, e98899 (2014).","journal-title":"PloS One"},{"key":"10784_CR14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3389\/fimmu.2013.00397","volume":"4","author":"A Neerincx","year":"2013","unstructured":"Neerincx, A., Castro, W., Guarda, G. & Kufer, T. A. NLRC5, at the heart of antigen presentation. Front. Immunol. 4, 397 (2013).","journal-title":"Front. Immunol."},{"key":"10784_CR15","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s13238-012-2109-3","volume":"4","author":"Y Yao","year":"2013","unstructured":"Yao, Y. & Qian, Y. Expression regulation and function of NLRC5. Protein Cell 4, 168\u2013175 (2013).","journal-title":"Protein Cell"},{"key":"10784_CR16","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3389\/fimmu.2017.00150","volume":"8","author":"S Benko","year":"2017","unstructured":"Benko, S., Kovacs, E. G., Hezel, F. & Kufer, T. A. NLRC5 functions beyond MHC I regulation\u2014what do we know so far? Front. Immunol. 8, 150 (2017).","journal-title":"Front. Immunol."},{"key":"10784_CR17","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/nri3339","volume":"12","author":"KS Kobayashi","year":"2012","unstructured":"Kobayashi, K. S. & van den Elsen, P. J. NLRC5: a key regulator of MHC class I-dependent immune responses. Nat. Rev. Immunol. 12, 813\u2013820 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"10784_CR18","doi-asserted-by":"publisher","first-page":"13794","DOI":"10.1073\/pnas.1008684107","volume":"107","author":"TB Meissner","year":"2010","unstructured":"Meissner, T. B. et al. NLR family member NLRC5 is a transcriptional regulator of MHC class I genes. Proc. Natl Acad. Sci. USA 107, 13794\u201313799 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10784_CR19","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.bbrc.2012.01.104","volume":"418","author":"TB Meissner","year":"2012","unstructured":"Meissner, T. B., Li, A., Liu, Y. J., Gagnon, E. & Kobayashi, K. S. The nucleotide-binding domain of NLRC5 is critical for nuclear import and transactivation activity. Biochem. Biophys. Res. Commun. 418, 786\u2013791 (2012).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10784_CR20","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.cell.2010.03.040","volume":"141","author":"J Cui","year":"2010","unstructured":"Cui, J. et al. NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways. Cell 141, 483\u2013496 (2010).","journal-title":"Cell"},{"key":"10784_CR21","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s10753-013-9804-y","volume":"37","author":"L Li","year":"2014","unstructured":"Li, L., Xu, T., Huang, C., Peng, Y. & Li, J. NLRC5 mediates cytokine secretion in RAW264.7 macrophages and modulated by the JAK2\/STAT3 pathway. Inflammation 37, 835\u2013847 (2014).","journal-title":"Inflammation"},{"key":"10784_CR22","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1096\/fj.201700511RR","volume":"32","author":"P Luan","year":"2018","unstructured":"Luan, P. et al. NLRC5 deficiency ameliorates diabetic nephropathy through alleviating inflammation. FASEB J. 32, 1070\u20131084 (2018).","journal-title":"FASEB J."},{"key":"10784_CR23","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle, B. W. et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 135, e927\u2013e999 (2017).","journal-title":"Circulation"},{"key":"10784_CR24","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/cr.2012.56","volume":"22","author":"Y Yao","year":"2012","unstructured":"Yao, Y. et al. NLRC5 regulates MHC class I antigen presentation in host defense against intracellular pathogens. Cell Res. 22, 836\u2013847 (2012).","journal-title":"Cell Res."},{"key":"10784_CR25","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.4049\/jimmunol.1102671","volume":"188","author":"F Staehli","year":"2012","unstructured":"Staehli, F. et al. NLRC5 deficiency selectively impairs MHC class I-dependent lymphocyte killing by cytotoxic T cells. J. Immunol. 188, 3820\u20133828 (2012).","journal-title":"J. Immunol."},{"key":"10784_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10554","volume":"7","author":"K Ludigs","year":"2016","unstructured":"Ludigs, K. et al. NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions. Nat. Commun. 7, 10554 (2016).","journal-title":"Nat. Commun."},{"key":"10784_CR27","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1161\/CIRCULATIONAHA.108.845461","volume":"120","author":"SM King","year":"2009","unstructured":"King, S. M. et al. Platelet dense-granule secretion plays a critical role in thrombosis and subsequent vascular remodeling in atherosclerotic mice. Circulation 120, 785\u2013791 (2009).","journal-title":"Circulation"},{"key":"10784_CR28","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1093\/cvr\/cvs135","volume":"95","author":"P Lacolley","year":"2012","unstructured":"Lacolley, P., Regnault, V., Nicoletti, A., Li, Z. & Michel, J. B. The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles. Cardiovasc. Res. 95, 194\u2013204 (2012).","journal-title":"Cardiovasc. Res."},{"key":"10784_CR29","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1161\/ATVBAHA.118.310223","volume":"38","author":"MW Majesky","year":"2018","unstructured":"Majesky, M. W. Vascular development. Arterioscler. Thromb. Vasc. Biol. 38, e17\u2013e24 (2018).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10784_CR30","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1161\/CIRCULATIONAHA.116.026046","volume":"136","author":"WL Cheng","year":"2017","unstructured":"Cheng, W. L. et al. Interferon regulatory factor 4 inhibits neointima formation by engaging Kruppel-like factor 4 signaling. Circulation 136, 1412\u20131433 (2017).","journal-title":"Circulation"},{"key":"10784_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.imbio.2011.08.011","volume":"217","author":"M Lamkanfi","year":"2012","unstructured":"Lamkanfi, M. & Kanneganti, T. D. Regulation of immune pathways by the NOD-like receptor NLRC5. Immunobiology 217, 13\u201316 (2012).","journal-title":"Immunobiology"},{"key":"10784_CR32","doi-asserted-by":"publisher","first-page":"e1005088","DOI":"10.1371\/journal.pgen.1005088","volume":"11","author":"K Ludigs","year":"2015","unstructured":"Ludigs, K. et al. NLRC5 exclusively transactivates MHC class I and related genes through a distinctive SXY module. PLoS Genet. 11, e1005088 (2015).","journal-title":"PLoS Genet."},{"key":"10784_CR33","doi-asserted-by":"publisher","first-page":"26046","DOI":"10.1074\/jbc.M703652200","volume":"282","author":"Y Xu","year":"2007","unstructured":"Xu, Y., Farmer, S. R. & Smith, B. D. Peroxisome proliferator-activated receptor gamma interacts with CIITA x RFX5 complex to repress type I collagen gene expression. J. Biol. Chem. 282, 26046\u201326056 (2007).","journal-title":"J. Biol. Chem."},{"key":"10784_CR34","doi-asserted-by":"publisher","first-page":"e0175855","DOI":"10.1371\/journal.pone.0175855","volume":"12","author":"EWY Tung","year":"2017","unstructured":"Tung, E. W. Y., Ahmed, S., Peshdary, V. & Atlas, E. Firemaster(R) 550 and its components isopropylated triphenyl phosphate and triphenyl phosphate enhance adipogenesis and transcriptional activity of peroxisome proliferator activated receptor (Ppargamma) on the adipocyte protein 2 (aP2) promoter. PloS ONE 12, e0175855 (2017).","journal-title":"PloS One"},{"key":"10784_CR35","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1002\/cncr.27865","volume":"119","author":"KF Cheung","year":"2013","unstructured":"Cheung, K. F. et al. CITED2 is a novel direct effector of peroxisome proliferator-activated receptor gamma in suppressing hepatocellular carcinoma cell growth. Cancer 119, 1217\u20131226 (2013).","journal-title":"Cancer"},{"key":"10784_CR36","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1161\/CIRCRESAHA.107.164384","volume":"102","author":"SZ Duan","year":"2008","unstructured":"Duan, S. Z., Usher, M. G. & Mortensen, R. M. Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature. Circ. Res. 102, 283\u2013294 (2008).","journal-title":"Circ. Res."},{"key":"10784_CR37","doi-asserted-by":"publisher","first-page":"816856","DOI":"10.1155\/2015\/816856","volume":"2015","author":"AJ Kroker","year":"2015","unstructured":"Kroker, A. J. & Bruning, J. B. Review of the structural and dynamic mechanisms of PPARgamma partial agonism. PPAR Res. 2015, 816856 (2015).","journal-title":"PPAR Res."},{"key":"10784_CR38","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/cvr\/cvr238","volume":"92","author":"LL Zhang","year":"2011","unstructured":"Zhang, L. L. et al. PPARgamma attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells. Cardiovasc. Res. 92, 484\u2013493 (2011).","journal-title":"Cardiovasc. Res."},{"key":"10784_CR39","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.4049\/jimmunol.1401065","volume":"193","author":"A Neerincx","year":"2014","unstructured":"Neerincx, A. et al. The N-terminal domain of NLRC5 confers transcriptional activity for MHC class I and II gene expression. J. Immunol. 193, 3090\u20133100 (2014).","journal-title":"J. Immunol."},{"key":"10784_CR40","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1124\/pr.114.010090","volume":"68","author":"S Goulopoulou","year":"2016","unstructured":"Goulopoulou, S., McCarthy, C. G. & Webb, R. C. Toll-like receptors in the vascular system: sensing the dangers within. Pharm. Rev. 68, 142\u2013167 (2016).","journal-title":"Pharm. Rev."},{"key":"10784_CR41","doi-asserted-by":"publisher","first-page":"e1151593","DOI":"10.1080\/2162402X.2016.1151593","volume":"5","author":"GM Rodriguez","year":"2016","unstructured":"Rodriguez, G. M. et al. NLRC5 elicits antitumor immunity by enhancing processing and presentation of tumor antigens to CD8(+) T lymphocytes. Oncoimmunology 5, e1151593 (2016).","journal-title":"Oncoimmunology"},{"key":"10784_CR42","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/cr.2012.53","volume":"22","author":"Y Tong","year":"2012","unstructured":"Tong, Y. et al. Enhanced TLR-induced NF-kappaB signaling and type I interferon responses in NLRC5 deficient mice. Cell Res. 22, 822\u2013835 (2012).","journal-title":"Cell Res."},{"key":"10784_CR43","doi-asserted-by":"publisher","first-page":"24294","DOI":"10.1074\/jbc.M112.364604","volume":"287","author":"GR Robbins","year":"2012","unstructured":"Robbins, G. R. et al. Regulation of class I major histocompatibility complex (MHC) by nucleotide-binding domain, leucine-rich repeat-containing (NLR) proteins. J. Biol. Chem. 287, 24294\u201324303 (2012).","journal-title":"J. Biol. Chem."},{"key":"10784_CR44","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1161\/CIRCRESAHA.116.301313","volume":"116","author":"P Libby","year":"2015","unstructured":"Libby, P. & Hansson, G. K. Inflammation and immunity in diseases of the arterial tree: players and layers. Circ. Res. 116, 307\u2013311 (2015).","journal-title":"Circ. Res."},{"key":"10784_CR45","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1083\/jcb.201505091","volume":"211","author":"Q Meng","year":"2015","unstructured":"Meng, Q. et al. Reversible ubiquitination shapes NLRC5 function and modulates NF-kappaB activation switch. J. Cell Biol. 211, 1025\u20131040 (2015).","journal-title":"J. Cell Biol."},{"key":"10784_CR46","doi-asserted-by":"publisher","first-page":"631","DOI":"10.2174\/1568026616666160617072521","volume":"17","author":"M Dominguez","year":"2017","unstructured":"Dominguez, M., Alvarez, S. & de Lera, A. R. Natural and structure-based RXR ligand scaffolds and their functions. Curr. Top. Med. Chem. 17, 631\u2013662 (2017).","journal-title":"Curr. Top. Med. Chem."},{"key":"10784_CR47","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.yjmcc.2014.02.012","volume":"72","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. TNF-alpha promotes early atherosclerosis by increasing transcytosis of LDL across endothelial cells: crosstalk between NF-kappaB and PPAR-gamma. J. Mol. Cell. Cardiol. 72, 85\u201394 (2014).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10784_CR48","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.cmet.2014.08.005","volume":"20","author":"RE Soccio","year":"2014","unstructured":"Soccio, R. E., Chen, E. R. & Lazar, M. A. Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes. Cell Metab. 20, 573\u2013591 (2014).","journal-title":"Cell Metab."},{"key":"10784_CR49","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/S0140-6736(11)61662-0","volume":"378","author":"D Hillaire-Buys","year":"2011","unstructured":"Hillaire-Buys, D., Faillie, J. L. & Montastruc, J. L. Pioglitazone and bladder cancer. Lancet 378, 1543\u20131544 (2011). author reply 1544\u20131545.","journal-title":"Lancet"},{"key":"10784_CR50","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.2174\/1381612823666161118145850","volume":"23","author":"EA Ivanova","year":"2017","unstructured":"Ivanova, E. A., Myasoedova, V. A., Melnichenko, A. A. & Orekhov, A. N. Peroxisome proliferator-activated receptor (PPAR) gamma agonists as therapeutic agents for cardiovascular disorders: focus on atherosclerosis. Curr. Pharm. Des. 23, 1119\u20131124 (2017).","journal-title":"Curr. Pharm. Des."},{"key":"10784_CR51","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.bbrc.2016.09.101","volume":"479","author":"D Su","year":"2016","unstructured":"Su, D. et al. Cited2 participates in cardiomyocyte apoptosis and maternal diabetes-induced congenital heart abnormality. Biochem. Biophys. Res. Commun. 479, 887\u2013892 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10784_CR52","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.atherosclerosis.2015.08.037","volume":"243","author":"S Lim","year":"2015","unstructured":"Lim, S. et al. Effect of a new PPAR-gamma agonist, lobeglitazone, on neointimal formation after balloon injury in rats and the development of atherosclerosis. Atherosclerosis 243, 107\u2013119 (2015).","journal-title":"Atherosclerosis"},{"key":"10784_CR53","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1210\/me.2013-1427","volume":"28","author":"MB Wright","year":"2014","unstructured":"Wright, M. B., Bortolini, M., Tadayyon, M. & Bopst, M. Minireview: Challenges and opportunities in development of PPAR agonists. Mol. Endocrinol. 28, 1756\u20131768 (2014).","journal-title":"Mol. Endocrinol."},{"key":"10784_CR54","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1161\/ATVBAHA.116.307923","volume":"37","author":"J Zhuang","year":"2017","unstructured":"Zhuang, J. et al. The Yin-Yang dynamics of DNA methylation is the key regulator for smooth muscle cell phenotype switch and vascular remodeling. Arterioscler. Thromb. Vasc. Biol. 37, 84\u201397 (2017).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10784_CR55","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1161\/HYPERTENSIONAHA.115.05332","volume":"66","author":"DM Hasan","year":"2015","unstructured":"Hasan, D. M. et al. Smooth muscle peroxisome proliferator-activated receptor gamma plays a critical role in formation and rupture of cerebral aneurysms in mice in vivo. Hypertension 66, 211\u2013220 (2015).","journal-title":"Hypertension"},{"key":"10784_CR56","doi-asserted-by":"publisher","first-page":"26223","DOI":"10.1074\/jbc.M110.109736","volume":"285","author":"A Neerincx","year":"2010","unstructured":"Neerincx, A. et al. A role for the human nucleotide-binding domain, leucine-rich repeat-containing family member NLRC5 in antiviral responses. J. Biol. Chem. 285, 26223\u201326232 (2010).","journal-title":"J. Biol. Chem."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10784-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10784-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10784-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:11:15Z","timestamp":1671235875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10784-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,28]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["10784"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-10784-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,28]]},"assertion":[{"value":"28 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2882"}}